Neurolixis Inc. is a biopharmaceutical company focused on the discovery and development of novel drugs for the treatment of human central nervous system diseases including movement disorders, autism spectrum disorders, depression and pain.
Looking for a particular Neurolixis employee's phone or email?
The Neurolixis annual revenue was $4 million in 2026.
Adrian Newman-Tancredi is the Co-Founder and Chief Executive Officer of Neurolixis.
5 people are employed at Neurolixis.
Neurolixis is based in Park Ridge, New Jersey.
The NAICS codes for Neurolixis are [54171, 54, 5417, 32, 325, 541711, 541].
The SIC codes for Neurolixis are [87, 873].